Weekly Special May 18th thru May 24th Glutathione 200 mg IM Injection $50
Weekly Special May 18th thru May 24th Glutathione 200 mg IM Injection $50
Signed in as:
filler@godaddy.com
One class of drugs called glucagon-like peptide-1 (GLP-1) agonists is used to treat both obesity and type 2 diabetes. GLP-1 is a hormone that's found in your digestive system. It's released when you eat and tells your body to make insulin to control your blood sugar. It also slows down how quickly your food moves from your stomach to your intestines, and it gives your brain the signal that you feel full. A GLP-1 agonist can give your system a boost.
Ozempic isn't approved for weight management, although many people taking it do lose weight. It's sometimes prescribed off-label for that purpose. It is approved for long term use.
Novo Nordisk, list price is about $936 for a 4-week supply. Novo Nordisk has a savings program that may help with your out-of-pocket costs.
The largest clinical trial before FDA approval, people taking highest dose (2.4 mg) lost, on average, more than 12% of their body wt over 17 months. It's a shot you give yourself once a week prefilled pen in skin of your abdomen, thigh, or upper arm. Start with a low dose, 0.25 mg, increase it gradually over several months to either 1.7 or 2.4 milligrams. Approved for long term use. Novo Nordisk, says the list price is $1,349 for a 4-week supply.
Compounded semaglutide is a medication that’s custom-made for you by a compounding pharmacy. It contains the active ingredient semaglutide, which is found in FDA-approved medications: Ozempic & Wegovy.
Does this mean that compounded semaglutide is the same as Ozempic & Wegovy? The short answer: No. And these products are not “generic Ozempic” or “generic Wegovy.” There are no FDA-approved generics of these mediations yet.
The FDA may allow semaglutide to be compounded during a shortage if the pharmacy meets certain requirements, including:
New class of drugs treats both DMII & obesity, Works with both of the main digestive hormones that tell your body to make insulin: GLP-1 & glucose-dependent insulinotropic polypeptide (GIP). Tirzepatide is the first such drug that's made it to market. FDA approved it for DMII management in 2022 & weight control in November 2023. Tirzepatide imitates both GLP-1 & GIP, increasing your body's production of insulin & lowering your blood glucose levels & slows down gastric emptying.
Tirzepatide mimics two hormones, one regulates insulin when blood sugar rises & the gut hormone. Together, they dampen appetite so you eat less. Zepbound injection you give yourself once week in skin of stomach, upper arm, or thigh prefilled pen. The dose goes up over several months until reach target dose, which can be 5, 10, or 15 mg. Eli Lilly, says the list price is about $1,060 for 4-week supply. There's coupon available from Eli Lilly. Cash pay, no insurance: vial 2.5mg $399 5mg $549
Mounjaro activates receptors for both the hormones GLP-1 and GIP and leads to improved blood sugar control. It isn't approved for treating obesity, but during tirzepatide diabetes trials, researchers noted people who got tirzepatide lost much more weight than those on standard diabetes therapy. Injection you give yourself once a week in the skin of your stomach, upper arm, or thigh, using a prefilled pen. Eli Lilly, says the list price is about $1,070 for a 1-month supply.
Naltrexone HCl and bupropion (Contrave) (This is an oral pill, not an injection) Must be taken daily. Contrave is a combination of two FDA-approved drugs, naltrexone and bupropion, in an extended-release formula. Naltrexone is approved to treat alcohol and opioid dependence. Bupropion is approved to treat depression and seasonal affective disorder and help people stop smoking. Appears to signal your brain to lower appetite. Cost about $700-$800 for a 1-month supply.
A special lipotropics fat burning combination of methionine, inositol, choline, and B12. Each of these ingredients helps the body turn fat into energy and are also powerful antioxidants. In addition to the Lipotropics blend , Lipo-Mino also contains a mixture of B vitamins which further help to facilitate fat loss and increase energy. The formula is then completed by adding ingredients to reduce appetite, build muscle and promote a healthy immune system.
Weekly self-administered injection:
Secretropin is a non-peptide, secretagogue that has clinically been found to increase the production and release of GH (as measured by IGF-1 and IGFBP-3) through a number of pathways; suppression of Somatostatin, stimulation of GHRH, Dopanergic, Gherlin, and a Non-specific Synthetic Receptors. Additionally, Secretropin is believed to directly stimulate pituitary Somatrophs thereby increasing the production and release of GH. Secretropin is classified as a natural food supplement and not a drug.
No actual appointment is necessary, there is a short questionnaire form to complete before we will order for you. This is to ensure there are no interactions or contraindications to the use of this supplement.
Addyi is the first and only FDA-approved pill proven effective for Hypoactive Sexual Desire Disorder (HSDD) in certain premenopausal women.
Addyi (flibanserin) works by primarily acting as a serotonin modulator, primarily acting as an agonist at 5-HT1A receptors and an antagonist at 5-HT2A receptors, which results in a net decrease of serotonin activity in the brain while increasing the activity of other neurotransmitters like dopamine and norepinephrine, potentially leading to improved sexual desire by balancing these neurotransmitter levels in brain circuits related to sexual function; essentially, it reduces the inhibitory effect
Copyright © 2024 Resurrection Medical Care (Resurrection Medical Aesthetics, LLC) - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.